osaterone acetate has been researched along with Adenoma, Prostatic in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (57.14) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Bedin, S; Contiero, B; Ferré-Dolcet, L; Frigotto, L; Romagnoli, S | 1 |
| Janowski, T; Socha, P; Tobolski, D; Zduńczyk, S | 1 |
| Barbon, AR; Glendewar, G; Haworth, P; Ordóñez, IA; Pocknell, A; Routh, A | 1 |
| Albouy, M; Eun, HM; Maynard, L; Sanquer, A | 1 |
| Fukabori, Y; Hamataki, N; Honma, S; Ito, K; Kushitani, M; Mieda, M; Suzuki, K; Takezawa, Y; Yamanaka, H | 1 |
| Inada, R; Mizokami, A; Murakoshi, M; Suzuki, M; Tagawa, M; Watanabe, K | 1 |
| Kishimoto, T; Maekawa, T; Nakatani, T; Nishisaka, N; Wada, S; Yamamoto, K; Yasumoto, R | 1 |
| Aoki, H; Aoki, M; Arai, Y; Komatsu, Y; Kubo, T; Kumamoto, Y; Sato, Y; Tsukamoto, T; Umehara, T; Yoshida, O | 1 |
| Akiyama, T; Kaneko, S; Kurita, T; Mizunaga, M; Park, YC; Yachiku, S | 1 |
| Fukuda, S; Hori, T; Kawakami, E; Orima, H; Shimizu, M; Tsutsu, T | 1 |
| Hori, T; Kawakami, E; Shimizu, M; Tatsuzawa, C; Tsutsui, T | 1 |
| Fukabori, Y; Hamataki, N; Honma, S; Kushitani, M; Mieda, M; Takezawa, Y; Yamanaka, H | 1 |
| Honma, S; Inada, R; Makino, M; Mieda, M; Murakoshi, M; Suzuki, M; Tagawa, M; Takezawa, Y; Yamanaka, H | 1 |
| Honma, S; Inada, R; Makino, M; Mieda, M; Murakoshi, M; Suzuki, M; Yamanaka, H | 1 |
5 trial(s) available for osaterone acetate and Adenoma, Prostatic
| Article | Year |
|---|---|
The effects of osaterone acetate on clinical signs and prostate volume in dogs with benign prostatic hyperplasia.
Topics: Androgen Antagonists; Animals; Chlormadinone Acetate; Dog Diseases; Dogs; Male; Prostate; Prostatic Hyperplasia | 2018 |
Efficacies of osaterone and delmadinone in the treatment of benign prostatic hyperplasia in dogs.
Topics: Androgen Antagonists; Animals; Chlormadinone Acetate; Dog Diseases; Dogs; Drug Administration Schedule; Male; Prostatic Hyperplasia | 2008 |
[The effect of TZP-4238, an anti-androgen drug, on renal function].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Chlormadinone Acetate; Hemodynamics; Humans; Kidney; Male; Middle Aged; Prostatic Hyperplasia | 1994 |
[Study of clinical usefulness of an antiandrogen, TZP-4238, as a drug for treatment of benign prostatic hypertrophy--its influence on sexual function].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Chlormadinone Acetate; Double-Blind Method; Ejaculation; Humans; Male; Middle Aged; Penile Erection; Prostatic Hyperplasia; Sex; Sexual Behavior | 1994 |
[Clinical study of TZP-4238 on patients with benign prostatic hypertrophy--with special reference to urodynamics].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Chlormadinone Acetate; Humans; Male; Middle Aged; Prostatic Hyperplasia; Urinary Bladder Neck Obstruction; Urodynamics | 1994 |
9 other study(ies) available for osaterone acetate and Adenoma, Prostatic
| Article | Year |
|---|---|
Prostatic fluid composition and semen quality in dogs with benign prostatic hyperplasia undergoing treatment with osaterone acetate.
Topics: Animals; Chlormadinone Acetate; Dog Diseases; Dogs; Male; Prostatic Hyperplasia; Semen Analysis | 2022 |
DIAGNOSIS AND MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA IN A PIED TAMARIN (SAGUINUS BICOLOR).
Topics: Androgen Antagonists; Animals; Chlormadinone Acetate; Male; Monkey Diseases; Prostatic Hyperplasia; Saguinus | 2016 |
Effects of a new steroidal antiandrogen, TZP-4238 (17 alpha-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3, 20-dione), on spontaneously developed canine benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgen Antagonists; Animals; Chlormadinone Acetate; Contraceptives, Oral; Dihydrotestosterone; Disease Models, Animal; Dogs; Male; Organ Size; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Testosterone; Ultrasonography | 1995 |
Inhibition of steroid-induced prostatic hyperplasia in rats by treatment with anti-androgen (TZP-4238).
Topics: Androgen Antagonists; Animals; Bromodeoxyuridine; Chlormadinone Acetate; Drug Interactions; Estradiol; Glutathione Peroxidase; Male; Orchiectomy; Organ Size; Prostate; Prostatic Hyperplasia; Rats; Rats, Wistar; Receptors, Androgen; Testosterone | 1993 |
Regression of prostatic hypertrophy by osaterone acetate in dogs.
Topics: Administration, Oral; Androgen Antagonists; Animals; Chlormadinone Acetate; Dog Diseases; Dogs; Luteinizing Hormone; Male; Prostatic Hyperplasia; Testosterone | 2000 |
Effect of osaterone acetate administration on prostatic regression rate, peripheral blood hormone levels and semen quality in dogs with benign prostatic hypertrophy.
Topics: Androgen Antagonists; Animals; Chlormadinone Acetate; Dog Diseases; Dogs; Luteinizing Hormone; Male; Orchiectomy; Prostate; Prostatic Hyperplasia; Semen; Sperm Count; Testosterone | 2001 |
Effects of the new steroidal antiandrogen TZP-4238 on hormone-induced canine prostatic hyperplasia.
Topics: Androstane-3,17-diol; Animals; Chlormadinone Acetate; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Dogs; Male; Organ Size; Oxidoreductases; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Ultrasonography | 1992 |
Inhibitory influence of a new steroidal anti-androgen, TZP-4238, on prostatic hyperplasia in the beagle dog.
Topics: Animals; Chlormadinone Acetate; Dogs; Female; Immunohistochemistry; Male; Organ Size; Pituitary Gland; Prostatic Hyperplasia; Testis; Testosterone | 1992 |
Effect of anti-androgen (TZP-4238) on steroid-induced canine prostatic hyperplasia. Light and electron microscopic investigations.
Topics: Administration, Oral; Androgen Antagonists; Androstane-3,17-diol; Animals; Chlormadinone Acetate; Dogs; Estradiol; Male; Microscopy, Electron; Orchiectomy; Organ Size; Prostatic Hyperplasia | 1990 |